Introduction The introduction to the Canadian market of three new drugs for the management of Parkinson’s disease (PD) in the last 2 years (one of which has been withdrawn due to rare hepatic... Read More

 Introduction There are between 5000 and 8000 British Columbians with Parkinson's disease (PD). The vast majority of them are well treated with the medications outlined elsewhere in this... Read More

Introduction The management of Parkinson’s disease (PD) today is a complex and demanding task as more treatment options become available. The patient often poses challenging problems, which may be... Read More

Introduction Parkinson's disease is commonly associated with psychiatric morbidity, which includes depression, anxiety, and dopaminergic psychosis. These compound the patient's predicament.... Read More

Definition As we learn more about Parkinson’s disease and the other two common neurodegenerative disorders, Alzheimer’s disease and amyotrophic lateral sclerosis, the same pattern of information... Read More